Skip to main content
  • Book
  • © 2011

Diabetes - Perspectives in Drug Therapy

  • Features excellent reviews of international experts on cutting edge diabetes research
  • Provides a detailed up to date overview of cellular and molecular mechanisms involved in obesity driven development of type 2 diabetes
  • Focuses on potential novel drug targets, thus opening the way for innovative strategies in diabetes and obesity therapy
  • Includes supplementary material: sn.pub/extras

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 203)

Buy it now

Buying options

eBook USD 349.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 449.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 449.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (16 chapters)

  1. Front Matter

    Pages i-xiii
  2. Targeting Type 2 Diabetes

    • Christina Schwanstecher, Mathias Schwanstecher
    Pages 1-33
  3. Dual Acting and Pan-PPAR Activators as Potential Anti-diabetic Therapies

    • Monique Heald, Michael A. Cawthorne
    Pages 35-51
  4. Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes

    • Vincenzo Di Marzo, Fabiana Piscitelli, Raphael Mechoulam
    Pages 75-104
  5. SGLT Inhibitors as New Therapeutic Tools in the Treatment of Diabetes

    • Rolf K. H. Kinne, Francisco Castaneda
    Pages 105-126
  6. Nampt and Its Potential Role in Inflammation and Type 2 Diabetes

    • Antje Garten, Stefanie Petzold, Susanne Schuster, Antje Körner, Jürgen Kratzsch, Wieland Kiess
    Pages 147-164
  7. Overcoming Insulin Resistance with Ciliary Neurotrophic Factor

    • Tamara L. Allen, Vance B. Matthews, Mark A. Febbraio
    Pages 179-199
  8. Interleukin-Targeted Therapy for Metabolic Syndrome and Type 2 Diabetes

    • Kathrin Maedler, Gitanjali Dharmadhikari, Desiree M. Schumann, Joachim Størling
    Pages 257-278
  9. AMP-Activated Protein Kinase and Metabolic Control

    • Benoit Viollet, Fabrizio Andreelli
    Pages 303-330
  10. Mitochondria as Potential Targets in Antidiabetic Therapy

    • Paula I. Moreira, Catarina R. Oliveira
    Pages 331-356
  11. Research and Development of Glucokinase Activators for Diabetes Therapy: Theoretical and Practical Aspects

    • Franz M. Matschinsky, Bogumil Zelent, Nicolai M. Doliba, Klaus H. Kaestner, Jane M. Vanderkooi, Joseph Grimsby et al.
    Pages 357-401
  12. Erratum to Chapter 11: Interleukin-Targeted Therapy for Metabolic Syndrome and Type 2 Diabetes

    • Kathrin Maedler, Gitanjali Dharmadhikari, Desiree M. Schumann, Joachim Størling
    Pages E1-E1
  13. Back Matter

    Pages 403-408

About this book

The chapters of this book report cutting-edge research on molecular events in adiposity and type 2 diabetes, thus opening the way for innovative drug-based therapeutic strategies. It addresses all those who wish to keep in touch with recent developments in the field.

Editors and Affiliations

  • Fakultät Lebenswissenschaften Molekulare Pharmakologie und Toxikologie, Technische Universität Braunschweig, Braunschweig, Germany

    Mathias Schwanstecher

Bibliographic Information

Buy it now

Buying options

eBook USD 349.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 449.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 449.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access